Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
In theory it shouldn't matter. Since they changed the patient population(which should make a big difference) as well as the scoring system and they already saw decent results with the 200mg.
The P2a doesn't include a 200mg arm or mild patients. So anyone who tries to compare them is deceiving. The patient population is easier the dosing increased 50% and 100%(why because it's safe and we can) and the scoring system changed(read easier). We all will know the results soon.
Yeah those dang cancer trials usually only take about 18-24 months. Just a few $. Lol.
I think it's interesting to note how a company like AR@H who's stock has fallen by over 50% over the last few months has very little discussion yet here we have wailing and belly aching. Amazing!
Uh...I don't think that's the way it works "Dr". Lol! Good try!
The science has been moving forward. P results soon. B partnership opportunities moving forward.
Young biotech is a term describing the phase they are in regarding their development. If you don't have patience maybe it's time to move on because posting on an anonymous message board won't change the pps! Lol
Agreed! The noise the perpetual carpers are making suggest they are very nervous. The science keeps moving forward.
I not sure you can say that there is no manipulation or that the manipulation hasn't caused any long term problems for the company. I agree that young biotech companies have many challenges but we have experienced more than our fare share of manipulation.
As usual complete bull from the "doctor" please!
Ipix continues to move the drugs forwards! P results soon! Partnerships soon!
it's worked out great for AV@L.
Q1 is Q1 Jan 1 until end of march
Now your talkin!
As I said yesterday those who want to create uncertainty for ipix will use these flat days knowing there is no news coming for at least a month. Low volume days don't mean much. Keep your eyes on the science progression.
Any thoughts regarding how many other types of cancer B-OM could be used for other than Head and Neck?
I think it's very instructive to observe how people spend their time. Time is finite of course and the calories we expend during our day also have a very real cost. It's my observation that people always have an incentive to behave one way or another. I like many longs have watched as Leo and company do a great job creating value with numerous successful trials. His actions speak volumes. If you are concerned about ipix look at their actions. If your confused about someone's actions ask yourself what their incentive might be because not everyone's intentions are pure.
Now that is a pro rated comment!
The money gets us off otc which gets us institutional support. That's why the first deal is so important. We aren't a one trick pony.
Every deal is different but the up front money usually pales in comparison to the milestone payments. The milestone payments would stop the dilution.
Being aggressive and creating competition is very important. Very pro rated comment. Some people believed that Leo shouldn't have "wasted" the companies money going to the conference. Of course that is not a pro rated comment!
As has been discussed here iv does have some benefits but "Their patients were dosed by infusion multiple times a week for a number of hours." This will add a huge cost to the overall cost of the drug.
Again if you compare the results you will see we are the leader!
Obviously you didn't read the post by PP. Those "smart money" investors will probably be investing in IPIX and B-OM.
Dammit Cabel! Why do you keep doing such a great job refuting the negative posts?! ;)
We all agree that the numbers were small. But we have seen management take this type of information make the appropriate changes and be successful therefore we have faith that they are doing that in this trial. If you don't have faith in management and believe they are hiding something from you then move on.
I know for a fact that if somebody wanted to they could find information or lack of information on almost every trial of pharmaceutical company has run and then they could cast a shadow of a doubt in people's mind about why that information either wasn't given or isn't there. It's actually a good tactic if you're on the short side.
Here's a pattern I'm C. The company releases information from trials and you find something that they haven't released or didn't release or don't have the information yet and then jump on it that's the pattern I'm seeing.
Management has had success making changes to trials based on information. They made changes to the trial and now they are running the trial and it is almost finished have some faith. By the way the FDA saw all the information and they gave the go-ahead. They really do shy upon letting companies run trials without scientific information.
Remember b2a they gave to much to often had ae's and questionable results but our management made changes based on the information they had and then we came up with the next trial and had excellent results. This is why we have faith in the psoriasis trial. Our management has done it before and they will do it again.
The p2a was used to guide them in making decisions for the 2b. They made several changes, gave the info to the fda and were given the go ahead to proceed with the 2b. End of story.
That statement is absolutely ridiculous! The 2B proved the dose and helped bring forward the B-OM and B-UP trials.
What? Maybe you haven't been following company very long but poly had done the 2a trial and all they had to do was tweak it with Dr. J's help. The inflammatory properties were still in development. Why would you ask such a question? Wow and I thought you were a pro!
Thanks PP. Your analysis is awesome. I also think the AF/Mako crowd is pissed at Leo for not giving into the law suite but fighting them and beating them.
They are still waiting on all the data. No BP will do a deal until then.
The companies might want to see the data...call me crazy! We are very close and I am as anxious as any but have just a little patience.
If he doesn't go it's "why didn't he go...he's not doing his job blah blah" if he goes it's "he's wasting money...blah blah!" The fud is thick!
It's called leverage. The more people interested the more leverage. Also we have many indications.